SOHM India Receives Wholesale Pharmaceutical Drug License Opening Global Exports To African, Latin American, and Southeast Asian Target Markets
Company Expects Direct Manufacturing License of Generic Pharmaceuticals In Two Weeks Further Increasing Profit Margins and Scalability of Operations
BUENA PARK, CA, OCTOBER 21, 2008 – SOHM, Inc. (Pink Sheets: SHMN), a leading US based Import Export Organization specializing in global trading through China and India, announced today that SOHM, India has received its pharmaceutical drug license. This license opens global pharmaceutical drug sales to African, Latin American, and Southeast Asian target markets. The Company also expects its direct manufacturing license of generic pharmaceuticals within 2 weeks further increasing profit margins and the scalability of manufacturing operations. These licenses will allow for accelerated growth by establishing a corporate manufacturing hub located in India for the production and export of generic pharmaceuticals.
Vice President for Corporate Strategy at SOHM, Inc., stated, “Growth in generic pharmaceutical sales is expected to be strong in Africa, Latin America, and Southeast Asia and we are preparing now to take market share in these untapped markets. Emerging markets are key to the pharmaceutical industry’s future growth with more than 85 percent of world consumers remaining underserved or with limited access to medicines.”
About SOHM, Inc.
SOHM, Inc. is a leading US based Import Export Organization specializing in global trading of a diversified product portfolio ranging from Manufacturing, Medical Equipment, Pharmaceuticals and Chemicals.
The Company has established and maintains long standing relationships in China and India which are the world’s largest product suppliers. Our Asia-Pacific manufacturers allow us to import, export, and/or source quality products in China and India; sharply reducing business costs and increasing the profits of our client corporations.
Safe Harbor Statement
This press release contains statements, which may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact:
SOHM, Inc.
Investor Relations
(714) 522-6700
ir@sohm.com